M. Katherine Tolbert

High Impact

Associate Professor

University of Arkansas for Medical Sciences

faculty

22 h-index 112 pubs 1,441 cited

Research Areas

Links

ORCID

Is this your profile? Verify and claim your profile

OverviewAI-generated summary

M. Katherine Tolbert's research program focuses on the diagnosis and treatment of gastrointestinal diseases in dogs and cats. Her work has contributed to understanding the role of diet in managing chronic enteropathy in dogs and investigating associations between lifestyle factors and health outcomes in aging companion animals.

Dr. Tolbert's recent publications include studies on cognitive dysfunction and physical activity in older dogs, as well as the application of qPCR and DNA shotgun metagenomic sequencing for assessing the canine fecal microbiota. She has also been involved in developing clinical guidelines for fecal microbiota transplantation in companion animals. Her research network includes Simon R. Knowles from the University of Arkansas at Monticello, with whom she shares co-authored publications.

With over 100 peer-reviewed manuscripts and an h-index of 22, Dr. Tolbert has received recognition for her research contributions, including the Zoetis award for Excellence in Veterinary Research in 2018. Her scholarship metrics indicate a highly cited researcher.

Metrics

h-index: 22
Publications: 112
Citations: 1,441

Selected Publications

Orally administered cholestyramine increases fecal bile acid excretion in healthy dogs (2025) DOI
Fecal and Clinical Profiles of Dogs With Chronic Enteropathies Treated With Bile Acid Sequestrants for 5–47 Months: A Retrospective Case Series (2025) DOI
Comparing owner reported and genetic breed identification reveals high concordance in a large cohort from the Dog Aging Project (2025) DOI
Microbial Gene Profiling and Targeted Metabolomics in Fecal Samples of Dogs With Chronic Enteropathy With or Without Increased Dysbiosis Index (2025) DOI
Treatment of Hypovitaminosis D With Cholecalciferol in Dogs With Protein‐Losing Enteropathies: A Randomized, Double‐Blind, Placebo‐Controlled, Clinical Trial (2025) DOI
Adverse events after fecal microbiota transplantation in nine cats: a case series (2025) DOI
Pre-clinical enteropathy in healthy soft-coated wheaten terriers (2025) DOI
Test of Rapamycin in Aging Dogs (TRIAD): study design and rationale for a prospective, parallel-group, double-masked, randomized, placebo-controlled, multicenter trial of rapamycin in healthy middle-aged dogs from the Dog Aging Project (2025) DOI
Prolonged storage reduces viability of Peptacetobacter (Clostridium) hiranonis and core intestinal bacteria in fecal microbiota transplantation preparations for dogs (2025) DOI
Harnessing the microbiome: probiotics, antibiotics and their role in canine and feline gastrointestinal disease (2024) DOI
Pharmacodynamics of 2 dosages of orally administered esomeprazole in client-owned, healthy dogs: A prospective, crossover study (2024) DOI
Dysbiosis index and fecal concentrations of sterols, long-chain fatty acids and unconjugated bile acids in dogs with inflammatory protein-losing enteropathy (2024) DOI
Clinical Guidelines for Fecal Microbiota Transplantation in Companion Animals (2024) DOI
Dog and owner demographics impact dietary choices in Dog Aging Project cohort (2024) DOI
The companion dog as a model for inflammaging: a cross-sectional pilot study (2024) DOI